Vanguard Group’s Sana Biotechnology SANA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $32.4M | Buy |
|
|||||
|
2025
Q2 | $20.8M | Sell |
|
|||||
|
2025
Q1 | $13.2M | Sell |
|
|||||
|
2024
Q4 | $17.5M | Sell |
|
|||||
|
2024
Q3 | $54.8M | Buy |
|
|||||
|
2024
Q2 | $70.3M | Buy |
|
|||||
|
2024
Q1 | $122M | Buy |
|
|||||
|
2023
Q4 | $40M | Buy |
|
|||||
|
2023
Q3 | $35.5M | Buy |
|
|||||
|
2023
Q2 | $54M | Sell |
|
|||||
|
2023
Q1 | $29.7M | Buy |
|
|||||
|
2022
Q4 | $35.4M | Buy |
|
|||||
|
2022
Q3 | $53M | Buy |
|
|||||
|
2022
Q2 | $51.8M | Buy |
|
|||||
|
2022
Q1 | $63.4M | Sell |
|
|||||
|
2021
Q4 | $119M | Buy |
|
|||||
|
2021
Q3 | $171M | Buy |
|
|||||
|
2021
Q2 | $48.4M | Buy |
|
|||||
|
2021
Q1 | $77.9M | Buy |
|